144 related articles for article (PubMed ID: 36192709)
1. Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRI.
Liang J; Dai W; Li Z; Liang X; Xiao M; Xie C; Li X
BMC Cancer; 2022 Oct; 22(1):1033. PubMed ID: 36192709
[TBL] [Abstract][Full Text] [Related]
2. Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer.
Song XL; Kang HK; Jeong GW; Ahn KY; Jeong YY; Kang YJ; Cho HJ; Moon CM
World J Gastroenterol; 2016 Jun; 22(24):5520-31. PubMed ID: 27350730
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of tumor vascular normalization in colorectal cancer mouse mode induced by recombinant human endostatin by intravoxel incoherent motion diffusion-weighted magnetic resonance imaging].
Zhu SB; Huang JL; Pan JH; Ding H; Zhao XX; Zhang D; Shi CZ; Pan YL
Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):421-428. PubMed ID: 31216827
[No Abstract] [Full Text] [Related]
4. Application of IVIM-DWI in Detecting the Tumor Vasculogenic Mimicry Under Antiangiogenesis Combined With Oxaliplatin Treatment.
Liang J; Li Z; Li J; Peng C; Dai W; He H; Zeng S; Xie C
Front Oncol; 2020; 10():1376. PubMed ID: 32974136
[No Abstract] [Full Text] [Related]
5. Trastuzumab biosimilar HLX02 versus reference trastuzumab in patients with recurrent or metastatic HER2-positive breast cancer: a model-based economic evaluation for China.
Deng W; Hu J; Li M; Yang S; Xie Z; Chen J
Expert Rev Pharmacoecon Outcomes Res; 2022 Oct; 22(7):1117-1126. PubMed ID: 35899310
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy response evaluation in a mouse model of gastric cancer using intravoxel incoherent motion diffusion-weighted MRI and histopathology.
Cheng J; Wang Y; Zhang CF; Wang H; Wu WZ; Pan F; Hong N; Deng J
World J Gastroenterol; 2017 Mar; 23(11):1990-2001. PubMed ID: 28373765
[TBL] [Abstract][Full Text] [Related]
7. Monitoring Treatment Efficacy of Antiangiogenic Therapy Combined With Hypoxia-Activated Prodrugs Online Using Functional MRI.
Ma M; Liang J; Zhang D; Xu X; Cheng Q; Xiao Z; Shi C; Luo L
Front Oncol; 2021; 11():672047. PubMed ID: 33996599
[TBL] [Abstract][Full Text] [Related]
8. Monitoring tumour microenvironment changes during anti-angiogenesis therapy using functional MRI.
Liang J; Cheng Q; Huang J; Ma M; Zhang D; Lei X; Xiao Z; Zhang D; Shi C; Luo L
Angiogenesis; 2019 Aug; 22(3):457-470. PubMed ID: 31147887
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging-based approaches for detecting the efficacy of combining therapy following VEGFR-2 and PD-1 blockade in a colon cancer model.
Xu X; Ma M; Ye K; Zhang D; Chen X; Wu J; Mo X; Xiao Z; Shi C; Luo L
J Transl Med; 2024 Feb; 22(1):198. PubMed ID: 38395884
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equivalence Trial.
Xu B; Zhang Q; Sun T; Li W; Teng Y; Hu X; Bondarenko I; Adamchuk H; Zhang L; Trukhin D; Wang S; Zheng H; Tong Z; Shparyk Y; Wang Q;
BioDrugs; 2021 May; 35(3):337-350. PubMed ID: 33826080
[TBL] [Abstract][Full Text] [Related]
11. Performing IVIM-DWI using the multifunctional nanosystem for the evaluation of the antitumor microcirculation changes.
Gao P; Liu Y; Shi C; Liu Y; Luo L
MAGMA; 2020 Aug; 33(4):517-526. PubMed ID: 31897903
[TBL] [Abstract][Full Text] [Related]
12. Monitoring Bevacizumab-Induced Tumor Vascular Normalization by Intravoxel Incoherent Motion Diffusion-Weighted MRI.
Li B; Xu D; Zhou J; Wang SC; Cai YX; Li H; Xu HB
J Magn Reson Imaging; 2022 Aug; 56(2):427-439. PubMed ID: 34873766
[TBL] [Abstract][Full Text] [Related]
13. Detection of Hyperacute Reactions of Desacetylvinblastine Monohydrazide in a Xenograft Model Using Intravoxel Incoherent Motion DWI and R2* Mapping.
Liang J; Ma R; Chen H; Zhang D; Ye W; Shi C; Luo L
AJR Am J Roentgenol; 2019 Apr; 212(4):717-726. PubMed ID: 30699010
[TBL] [Abstract][Full Text] [Related]
14. Monitoring the Process of Endostar-Induced Tumor Vascular Normalization by Non-contrast Intravoxel Incoherent Motion Diffusion-Weighted MRI.
Pan JH; Zhu S; Huang J; Liang J; Zhang D; Zhao X; Ding H; Qin L; Shi C; Luo L; Pan Y
Front Oncol; 2018; 8():524. PubMed ID: 30483478
[TBL] [Abstract][Full Text] [Related]
15. Role of intravoxel incoherent motion MR imaging in preoperative assessing HER2 status of gastric cancers.
Ji C; Zhang Q; Guan W; Guo T; Chen L; Liu S; He J; Zhou Z
Oncotarget; 2017 Jul; 8(30):49293-49302. PubMed ID: 28514733
[TBL] [Abstract][Full Text] [Related]
16. Quantitative study of preoperative staging of gastric cancer using intravoxel incoherent motion diffusion-weighted imaging as a potential clinical index.
Zeng Q; Hong Y; Cheng J; Cai W; Zhuo H; Hou J; Wang L; Lu Y; Cai J
Eur J Radiol; 2021 Aug; 141():109627. PubMed ID: 34126429
[TBL] [Abstract][Full Text] [Related]
17. A multicenter real-world study comparing the clinical equivalence of trastuzumab biosimilar HLX02 and reference trastuzumab in the treatment of HER-2-positive breast cancer.
Deng W; Hu J; Yang S; Xie Z; Li M; Li J; Zhuang W; Chen J
Am J Cancer Res; 2023; 13(7):3113-3122. PubMed ID: 37559995
[TBL] [Abstract][Full Text] [Related]
18. Application of Intravoxel Incoherent Motion Diffusion-Weighted Imaging in Predicting and Monitoring Early Efficacy of Anti-Angiogenic Therapy in the C6 Glioma Rat Model.
Hou W; Xue Y; Qian Y; Pan H; Xu M; Shen Y; Li X; Yu Y
Front Oncol; 2021; 11():842169. PubMed ID: 35155219
[TBL] [Abstract][Full Text] [Related]
19. Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer.
Hu X; Ma Z; Xu B; Li S; Yao Z; Liang B; Wang J; Liao W; Lin L; Wang C; Zheng S; Wu Q; Huang Q; Yu L; Wang F; Shi M
Cancer Commun (Lond); 2023 Aug; 43(8):909-937. PubMed ID: 37434399
[TBL] [Abstract][Full Text] [Related]
20. Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+ breast cancer: preliminary results.
Sorace AG; Quarles CC; Whisenant JG; Hanker AB; McIntyre JO; Sanchez VM; Yankeelov TE
Breast Cancer Res Treat; 2016 Jan; 155(2):273-84. PubMed ID: 26791520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
